Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
7.85
-0.17 (-2.12%)
At close: Dec 12, 2025, 4:00 PM EST
7.70
-0.15 (-1.91%)
After-hours: Dec 12, 2025, 7:00 PM EST
Biodesix Market Cap
Biodesix has a market cap or net worth of $62.45 million as of December 12, 2025. Its market cap has decreased by -70.08% in one year.
Market Cap
62.45M
Enterprise Value
120.24M
1-Year Change
-70.08%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $62.45M, a decrease of -81.43%. That is a compound annual growth rate of -28.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 62.45M | -71.94% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |